Activation of insulin-like growth factor I receptor signaling pathway is critical for mouse plasma cell tumor growth |
| |
Authors: | Li W Hyun T Heller M Yam A Flechner L Pierce J H Rudikoff S |
| |
Affiliation: | Department of Oncology/Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA. wwl@gunet.georgetown.edu |
| |
Abstract: | Plasma cell neoplasia in humans generally occurs as multiple myeloma, an incurable form of cancer. Tumors with marked similarity can be induced in mice by a variety of agents, including chemicals, silicone, and oncogene-containing retroviruses, suggesting the use of murine tumors as an informative model to study plasma cell disease. Herein, we have focused on the role of insulin-like growth factor I receptor (IGF-IR) signaling in the development of plasma cell disease. The insulin receptor substrate 2/phosphatidylinositol 3'-kinase/p70S6K pathway was found to be either constitutively or IGF-I-dependently activated in all plasma cell tumors. Biological relevance was demonstrated in that plasma cell lines with up-regulated IGF-IR expression levels exhibited mitogenic responses to IGF-I. More importantly, expression of a dominant-negative mutant of IGF-IR in these lines strongly suppressed tumorigenesis in vivo. Taken together, these results demonstrate that up-regulation and activation of IGF-IR and the downstream signaling pathway involving insulin receptor substrate 2, phosphatidylinositol 3'-kinase, and p70S6K may play an important role in the development of a broad spectrum of plasma cell tumors. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|